Lisata Therapeutics, Inc.
LSTA
$2.26
$0.17568.44%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 31.25M | 35.86M | 38.26M | 43.35M | 50.54M |
Total Receivables | 1.80M | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.53M | 1.84M | 3.72M | 4.21M | 3.39M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 34.58M | 37.69M | 41.98M | 47.56M | 53.92M |
|
|||||
Total Current Assets | 34.58M | 37.69M | 41.98M | 47.56M | 53.92M |
Net Property, Plant & Equipment | 210.00K | 278.00K | 344.00K | 413.00K | 483.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 192.00K | 210.00K | 228.00K | 245.00K | 263.00K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 22.00K | 19.00K | 21.00K | 23.00K | 24.00K |
Total Assets | 35.00M | 38.20M | 42.57M | 48.24M | 54.69M |
|
|||||
Total Accounts Payable | 1.28M | 556.00K | 728.00K | 1.26M | 2.42M |
Total Accrued Expenses | 4.19M | 3.95M | 3.55M | 3.90M | 4.00M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 137.00K | 181.00K | 176.00K | 172.00K | 168.00K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 5.61M | 4.69M | 4.46M | 5.33M | 6.59M |
|
|||||
Total Current Liabilities | 5.61M | 4.69M | 4.46M | 5.33M | 6.59M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | 47.00K | 92.00K | 137.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 72.00K | 72.00K | 72.00K | 72.00K | 73.00K |
Total Liabilities | 5.69M | 4.76M | 4.58M | 5.50M | 6.80M |
|
|||||
Common Stock & APIC | 578.43M | 577.89M | 577.56M | 577.29M | 576.98M |
Retained Earnings | -548.07M | -543.46M | -538.53M | -533.48M | -528.08M |
Treasury Stock & Other | -789.00K | -740.00K | -785.00K | -812.00K | -750.00K |
Total Common Equity | 29.57M | 33.69M | 38.25M | 43.00M | 48.15M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 29.57M | 33.69M | 38.25M | 43.00M | 48.15M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -254.00K | -254.00K | -254.00K | -254.00K | -254.00K |
Total Equity | 29.32M | 33.44M | 38.00M | 42.74M | 47.89M |
|